Skip to main content
MedPathMedPath Home
Clinical Trials/NL-OMON32409
NL-OMON32409
Withdrawn
Not Applicable

thrombogenicity and platelet reactivity as risk factors for postoperative microemboli signals in patients undergoing carotid endarterectomy - MES (Micro Embolism Signal)

Academisch Ziekenhuis Maastricht0 sites100 target enrollmentTBD
Share to TwitterShare to FacebookShare to LinkedInShare to Reddit
Conditionsarteriosclerosisstroke1000796310003216

Overview

Phase
Not Applicable
Intervention
Not specified
Conditions
arteriosclerosis
Sponsor
Academisch Ziekenhuis Maastricht
Enrollment
100
Status
Withdrawn
Last Updated
last year
OverviewInvestigatorsEligibility CriteriaOutcomesSimilar Trials

Overview

Brief Summary

No summary available.

Registry
who.int
Start Date
TBD
End Date
TBD
Last Updated
last year
Study Type
Observational invasive

Investigators

Eligibility Criteria

Inclusion Criteria

  • •patients with an ischemic stroke or TIA (first episode or recurrent disease) AND:
  • •an ipislateral stenosis of the carotid artery for which operation of the carotid artery is indicated.
  • •Patients need to have an adequate transtemporal window for TCD monitoring og the ateria cerebri media
  • •Age \> 18 year and \< 90years

Exclusion Criteria

  • •proven coagulopathies
  • •active infections
  • •chronic inflammatory diseases
  • •anti\-phospholipid syndrome
  • •active malignancy
  • •recent cardiovascular intervention (\< 3 months)
  • •cardiac arrythmias
  • •postradiation stenosis of the carotid artery
  • •patients with exlusion criteria for MRi can participate in the study, they will not undergo MRI investigations. Exclusion criteria are: feroomagnetic implans, introcular iron splinters, vascular clips and claustrophobia.

Outcomes

Primary Outcomes

Not specified

Similar Trials

Not yet recruiting
Not Applicable
Thrombogenicity and platelet reactivity as risk factors for postoperative microemboli signals in patients undergoing carotid endarterectomy
NL-OMON25062MUMC100
Not yet recruiting
Not Applicable
Platelet function in 22q11.2 deletion syndrome
NL-OMON24347one60
Recruiting
Not Applicable
Exploring bleeding risk and platelet function combined with multiple omics techniques in 22q11.2 deletion syndromeDiGeorge syndromeVelocardiofacial syndrome100355341008362410039628
NL-OMON55192Medisch Universitair Ziekenhuis Maastricht60
Active, not recruiting
Phase 1
Assessment of platelet-dependent thrombosis by an ex vivo arterial injury model: a placebo controlled trial of Clopidogrel as antiplatelet therapy in patients with type 2 diabetes mellitus and coronary artery disease. - Platelet-dependent thrombosis: a placebo-controlled trial of antiplatelet therapy (Clopidogrel)Type 2 Diabetes Mellitus and Coronary Artery Disease
EUCTR2006-003745-16-GBewcastle upon Tyne Hospitals NHS Trust225
Completed
Not Applicable
Platelet reactivity, inflammation and endothelial dysfunction during and after exacerbation in chronic obstructive pulmonary disease (COPD) patients
NL-OMON46302Gelre Ziekenhuizen76